Affymetrix Inc.
In California, !%Affymetrix Inc.%! of Santa Clara has signed a definitive agreement to acquire eBioscience Inc. of San Diego for $330 million in cash, subject to certain customary adjustments. The transaction was expected to close late in fourth-quarter 2011. “With eBioscience, Affymetrix will significantly expand its addressable markets by adding an industry-leading portfolio of cell-based and immunoassays,” said Dr. Frank Witney, president and CEO of Affymetrix. “These new products are a critical part of our customers’ work flow in our key target markets of translational medicine, oncology and immunology.” The company expects to maintain eBioscience’s management team and operations in San Diego.
LATEST NEWS
- Quantinuum Launches 56-Qubit Quantum Computer: Week in Brief: 6/7/2024
Jun 7, 2024
- Atom Computing Lands Investment, Expands Overseas
Jun 7, 2024
- Optogenetic Stimulation Enables Fatigue-Resistant Muscle Control
Jun 6, 2024
- Quandela Launches Pilot Line for Qubit Devices
Jun 6, 2024
- Lattice Semiconductor Adds Interim CEO
Jun 6, 2024
- On-Chip Microcomb Laser Provides Greater Control
Jun 5, 2024
- Flexible, Stretchable Device Addresses Tuning Limitations in Structural Color
Jun 5, 2024
- Fusion Startup Xcimer Raises $100M, Plans Laser Prototype
Jun 4, 2024